Metastatic Uveal Melanoma Clinical Trials
0 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 2Phase 3
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
Replimune Inc.280 enrolled31 locationsNCT06581406
Recruiting
Phase 1
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
MelanomaMetastatic MelanomaUveal Melanoma+1 more
Memorial Sloan Kettering Cancer Center30 enrolled2 locationsNCT05607095
Recruiting
Phase 1Phase 2
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Cutaneous MelanomaMetastatic Uveal Melanoma
IDEAYA Biosciences336 enrolled15 locationsNCT03947385
Recruiting
Phase 2
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute32 enrolled4 locationsNCT06121180
Recruiting
Phase 2
Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute18 enrolled1 locationNCT07276386
Recruiting
Phase 1Phase 2
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, Recurrent+2 more
Novelwise Pharmaceutical Corporation36 enrolled3 locationsNCT07136181
Recruiting
Phase 1Phase 2
Tebentafusp-tebn With LDT in Metastatic UM
Metastatic Uveal Melanoma
Thomas Jefferson University109 enrolled1 locationNCT06626516
Recruiting
Phase 1Phase 2
Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
Uveal MelanomaMetastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
St Vincent's Hospital, Sydney8 enrolled2 locationsNCT07063875